HealthcareServices

Intravenous Solutions Market 2026–2030: Emerging Trends and Forecast Opportunities

February 25, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the intravenous solutions market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Intravenous Solutions Market expected to reach by 2030?

The intravenous solutions market size has experienced robust expansion in recent years. This market is projected to expand from $14.91 billion in 2025 to $16.05 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.6%. The historical growth of this market stems from factors such as an increase in hospital admissions and surgical procedures, the extensive application of IV fluids for dehydration management, the rising occurrence of chronic diseases, the critical and established role of IV therapy in intensive care, and the growing demand for electrolyte and glucose solutions.

The intravenous solutions market size is projected to undergo substantial growth in the next few years, reaching a valuation of $21.73 billion by 2030, at a compound annual growth rate (CAGR) of 7.9%. The expansion observed in this forecast period is attributed to the broadening of home healthcare and outpatient infusion services, an expanding aging population requiring nutritional support, the increasing adoption of personalized nutrition therapies, advancements in sterile packaging technologies, and a growing demand for long-term parenteral nutrition. Key trends anticipated during this period encompass a rising demand for intravenous hydration in acute and chronic care settings, an increasing utilization of parenteral nutrition in critical and geriatric care, a growing preference for ready-to-use IV solution formulations, the expansion of home-based IV therapy and infusion services, and an increasing focus on sterility and safety in IV solution manufacturing.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13465&type=smp

What Drivers Are Driving Adoption Within The Intravenous Solutions Market?

The expanding occurrence of cancer is projected to boost the intravenous solutions market in the coming years. Cancer refers to a collection of illnesses marked by unchecked cell multiplication, capable of infiltrating adjacent tissues and spreading throughout the body. Intravenous solutions play a crucial role in cancer therapy, facilitating the administration of chemotherapy medications and sustaining patient hydration during treatment. As an illustration, in February 2024, the World Health Organization, an intergovernmental body based in Switzerland, anticipated more than 35 million new cancer cases by 2050, an increase of 77% from the approximately 20 million cases recorded in 2022. Consequently, the rising incidence of cancer is a key factor propelling the expansion of the intravenous solutions market.

How Is The Intravenous Solutions Market Organized Into Various Segments?

The intravenous solutions market covered in this report is segmented –

1) By Product: Total Parenteral Nutrition, Peripheral Parenteral Nutrition

2) By Nutrients: Carbohydrates, Vitamins And Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, Other Nutrients

3) By Application: Basic Intravenous (IV) Solution, Nutritional Intravenous (IV) Solution, Blood Intravenous (IV) Solution, Drug Intravenous (IV) Solution, Irrigation Intravenous (IV) Solution

4) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings

Subsegments:

1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions, Multivitamin Solutions

2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions

Which Trends Are Expected To Influence The Intravenous Solutions Market In The Upcoming Years?

Major companies within the intravenous solutions market are concentrating on developing innovative syringes, such as pre-filled and ready-to-administer types, to secure a competitive edge. These pre-filled and ready-to-administer syringes come preloaded with medication, making them suitable for immediate application without requiring manual preparation or filling. For instance, in August 2023, GENIXUS Corp., a US-based healthcare company, launched KinetiXTM Rocuronium Bromide Injection in 5 mL and 10 mL ready-to-administer (RTA) syringes. These syringes are constructed from a transparent, durable polymer material, thereby eliminating the risks typically associated with glass syringes. Their pre-filled and ready-to-administer nature contributes to time savings and a reduction in medication errors. Rocuronium bromide injection is exclusively intended for intravenous use. Key attributes include RFID enablement with KitCheck, the latest kit and tray management technology, alongside intuitive labeling, and a color-coded plunger rod designed for rapid identification.

Who Are The Core Companies Influencing Trends In The Intravenous Solutions Market?

Major companies operating in the intravenous solutions market are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Intravenous Solutions Market?

North America was the largest region in the intravenous solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Intravenous Solutions Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13465&type=smp

Browse Through More Reports Similar to the Global Intravenous Solutions Market 2026, By The Business Research Company

Empty Intravenous Iv Bags Market Report 2026

https://www.thebusinessresearchcompany.com/report/empty-intravenous-iv-bags-global-market-report

Intravenous Iv Hydration Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/intravenous-iv-hydration-therapy-global-market-report

Intravenous Infusion Pumps Market Report 2026

https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795